Coherus, Shanghai Junshi Shares Gain After U.S. Approval For Nasopharyngeal Cancer Drug
U.S. approval “should address ongoing geopolitical concerns and reiterate importance of clinical data,” Jeffries said
Stay updated with breaking news from Xiong Jun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. approval “should address ongoing geopolitical concerns and reiterate importance of clinical data,” Jeffries said
VIENTIANE (Vientiane Times/Asia News Network): More foreign and local business operators are eyeing lucrative opportunities in Laos and ploughing more investment into the country, thanks to improved infrastructure and connectivity as a result of the Belt and Road Initiative (BRI).
HONG KONG, Mar 31, 2023 - (ACN Newswire) - On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam[1].From left to right: CEO of Junshi Biosciences,...
HONG KONG, Mar 31, 2023 - (ACN Newswire) - On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint
People from all walks of life in Anhui, Hainan, Hunan and Yunnan travel thousands of kilometers over